Influenza Virus and SARS-CoV-2 Vaccines
Adam Sandor, Michael Sturdivant, Jenny P.‐Y. Ting
Abstract
Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced diseases. This review will discuss the existing strategies for influenza vaccines and how these strategies have informed SARS-CoV-2 vaccines. It will also discuss new vaccine platforms and potential challenges for both viruses.
Topics & Concepts
PandemicVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirusLoomingMedicineCoronavirusLive attenuated influenza vaccineInfluenza A virusInfluenza vaccineOutbreakInfectious disease (medical specialty)DiseasePhysicsPathologyOpticsInfluenza Virus Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections research